Depomed (DEPO) Acquires Rights to Zipsor Caps

June 21, 2012 4:07 PM EDT Send to a Friend
Depomed, Inc. (Nasdaq: DEPO) has acquired all rights to Zipsor (diclofenac potassium) Liquid Filled Capsules from Xanodyne Pharmaceuticals, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login